Marketing a medical device: why what you say matters as much as what you build
If your product is a medical device, including software as a medical device, your marketing sits under a level of scrutiny most sectors never experience. Buyers are cautious, claims are checked, and the gap between what a product is approved to do and what its website implies it can do is exactly where trust is lost.
This article is about the marketing and commercial side of that reality. It is not regulatory advice. The MHRA publishes the official guidance on how medical devices are regulated in the UK, and those questions belong with that guidance and with regulatory specialists.
Your claims are part of your product
In most sectors, an optimistic headline is just marketing. In medical devices, the claims you make about what a product does are taken seriously by buyers, regulators and clinicians alike. A website that overstates capability does not just risk embarrassment; it can undermine procurement conversations that took months to build.
The commercial insight is counterintuitive but reliable: disciplined claims convert better in this market, because accuracy is what experienced buyers are looking for.
Know where your product sits, and say it clearly
The MHRA's guidance on regulating medical devices in the UK explains how devices are classified and what placing on the market involves, including UKCA and CE marking arrangements. Whether a product is a regulated device, and at what classification, shapes what responsible marketing looks like.
Buyers in the NHS and wider healthcare sector understand this landscape. Marketing that shows you understand it too, for example by being precise about intended purpose and status, signals a company that will be straightforward to work with.
Evidence is your best marketing asset
Medical device buyers are evidence buyers. Clinical evaluation, real-world use and published results carry more weight than any tagline. The marketing job is to make that evidence visible, findable and understandable, not to decorate it.
If your evidence is still developing, say so and show the pathway. A credible roadmap presented honestly builds more confidence than inflated claims that collapse under the first technical question.
Write for the whole buying group
Device purchases involve clinicians, procurement, finance, IT and governance teams. Each reads your marketing with a different question. Clinical audiences want outcomes and safety. Procurement wants clarity and stability. Finance wants the cost story.
Marketing that only speaks to one of these audiences slows every deal. A clear site structure that lets each reader find their answer quickly is one of the highest-value investments a MedTech company can make.
Where marketing fits
Good MedTech marketing is not louder marketing. It is more precise marketing: accurate claims, visible evidence, plain language and a presence that reassures every member of the buying group. That is the work we do with healthcare technology organisations, and it is what turns regulatory discipline into commercial advantage.
This article refers to a position current at the date above and is reviewed when the underlying guidance or policy changes. Clarity Media Co. comments on the marketing and commercial implications of developments in Digital Health and HealthTech. We do not provide clinical, regulatory, DTAC or legal advice.